{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:18:30Z","timestamp":1783167510173,"version":"3.54.6"},"reference-count":158,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["R01AR073324"],"award-info":[{"award-number":["R01AR073324"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["new investigator award"],"award-info":[{"award-number":["new investigator award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The metabolic rewiring of tumor cells and immune cells has been viewed as a promising source of novel drug targets. Many of the molecular pathways implicated in rheumatoid arthritis (RA) directly modify synovium metabolism and transform the resident cells, such as the fibroblast-like synoviocytes (FLS), and the synovial tissue macrophages (STM), toward an overproduction of enzymes, which degrade cartilage and bone, and cytokines, which promote immune cell infiltration. Recent studies have shown metabolic changes in stromal and immune cells from RA patients. Metabolic disruption in the synovium provide the opportunity to use in vivo metabolism-based imaging techniques for patient stratification and to monitor treatment response. In addition, these metabolic changes may be therapeutically targetable. Thus, resetting metabolism of the synovial membrane offers additional opportunities for disease modulation and restoration of homeostasis in RA. In fact, rheumatologists already use the antimetabolite methotrexate, a chemotherapy agent, for the treatment of patients with inflammatory arthritis. Metabolic targets that do not compromise systemic homeostasis or corresponding metabolic functions in normal cells could increase the drug armamentarium in rheumatic diseases for combination therapy independent of systemic immunosuppression. This article summarizes what is known about metabolism in synovial tissue cells and highlights chemotherapies that target metabolism as potential future therapeutic strategies for RA.<\/jats:p>","DOI":"10.3390\/jcm8050753","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T11:19:27Z","timestamp":1558955967000},"page":"753","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?"],"prefix":"10.3390","volume":"8","author":[{"given":"Elsa","family":"Sanchez-Lopez","sequence":"first","affiliation":[{"name":"Department of Pharmacology, UCSD School of Medicine, La Jolla, CA 92093-0663, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-6071","authenticated-orcid":false,"given":"Anyan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Medicine, UCSD School of Medicine, La Jolla, CA 92093-0663, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-9411","authenticated-orcid":false,"given":"Monica","family":"Guma","sequence":"additional","affiliation":[{"name":"Department of Medicine, UCSD School of Medicine, La Jolla, CA 92093-0663, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","article-title":"Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis","volume":"19","author":"Bustamante","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/art.40504","article-title":"Synovial cell metabolism and chronic inflammation in rheumatoid arthritis","volume":"70","author":"Falconer","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_3","unstructured":"Fearon, U., Hanlon, M.M., Wade, S.M., and Fletcher, J.M. (2018). Altered metabolic pathways regulate synovial inflammation in rheumatoid arthritis. Clin. Exp. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2016.1","article-title":"Metabolomics in rheumatic diseases: Desperately seeking biomarkers","volume":"12","author":"Guma","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Surowiec, I., Arlestig, L., Rantapaa-Dahlqvist, S., and Trygg, J. (2016). Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164196"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Alonso, A., Juli\u00e0, A., Vinaixa, M., Dom\u00e8nech, E., Fern\u00e1ndez-Nebro, A., Ca\u00f1ete, J.D., Ferrandiz, C., Tornero, J., Gisbert, J.P., and Nos, P. (2016). Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med., 14.","DOI":"10.1186\/s12916-016-0681-8"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar3243","article-title":"Diagnostic properties of metabolic perturbations in rheumatoid arthritis","volume":"13","author":"Madsen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_10","first-page":"240","article-title":"Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy","volume":"30","author":"Hugle","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kim, S., Hwang, J., Xuan, J., Jung, Y.H., Cha, H.-S., and Kim, K.H. (2014). Global Metabolite Profiling of Synovial Fluid for the Specific Diagnosis of Rheumatoid Arthritis from Other Inflammatory Arthritis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097501"},{"key":"ref_12","first-page":"130","article-title":"NMR-Based Serum Metabolomics Revealed Distinctive Metabolic Patterns in Reactive Arthritis Compared with Rheumatoid Arthritis","volume":"18","author":"Dubey","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/acs.jproteome.8b00455","article-title":"1H NMR Metabolomics Identifies Underlying Inflammatory Pathology in Osteoarthritis and Rheumatoid Arthritis Synovial Joints","volume":"17","author":"Anderson","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cuppen, B.V.J., Fu, J., van Wietmarschen, H.A., Harms, A.C., Koval, S., Marijnissen, A.C., peeters, J.J., Bijlsma, J.W., Tekstra, J., and van Laar, J.M. (2016). Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-\u03b1 Inhibitors in Rheumatoid Arthritis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163087"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000289","DOI":"10.1136\/rmdopen-2016-000289","article-title":"Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis","volume":"2","author":"Sweeney","year":"2016","journal-title":"RMD Open"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tatar, Z., Migne, C., Petera, M., Gaudin, P., Lequerre, T., Marotte, H., Tebib, J., Pujos Guillot, E., and Soubrier, M. (2016). Variations in the metabolome in response to disease activity of rheumatoid arthritis. BMC Musculoskelet. Disord., 17.","DOI":"10.1186\/s12891-016-1214-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13075-018-1729-2","article-title":"Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: Insights from systems biology","volume":"20","author":"Teitsma","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.2174\/1381612821666150310145758","article-title":"Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: Role of synovial pathobiology","volume":"21","author":"Astorri","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","article-title":"New learnings on the pathophysiology of RA from synovial biopsies","volume":"25","author":"Pitzalis","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2967\/jnumed.108.060103","article-title":"Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis","volume":"50","author":"Matsui","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Jeong, J.H., Lee, C.H., Ahn, B.C., Eun, J.S., Kim, N.R., Kang, J.W., Nam, E.J., and Kang, Y.M. (2019). Development and validation of an 18F-FDG PET\/CT-based tool for the evaluation of joint counts and disease activity in patients with rheumatoid arthritis. Arthritis Rheumatol.","DOI":"10.1002\/art.40860"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/1450-1147.215492","article-title":"Quantitative Metabolic Volumetric Product on 18Fluorine-2fluoro-2-deoxy-d-glucose-positron Emission Tomography\/Computed Tomography in Assessing Treatment Response to Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Multiparametric Analysis Integrating American College of Rheumatology\/European League Against Rheumatism Criteria","volume":"16","author":"Kumar","year":"2017","journal-title":"World J. Nucl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Okamura, K., Yonemoto, Y., Okura, C., Higuchi, T., Tsushima, Y., and Takagishi, K. (2014). Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET\/CT. BMC Musculoskelet. Disord., 15.","DOI":"10.1186\/1471-2474-15-393"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4329\/wjr.v4.i12.462","article-title":"Potential of 18F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies","volume":"4","author":"Vijayant","year":"2012","journal-title":"World J. Radiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-012-2282-x","article-title":"Correlation of 18F-FDG PET\/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs","volume":"40","author":"Roivainen","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_26","first-page":"6","article-title":"18F- FDG PET\/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab","volume":"2","author":"Fosse","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2011.06031.x","article-title":"FDG PET for rheumatoid arthritis: Basic considerations and whole-body PET\/CT","volume":"1228","author":"Kubota","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12149-009-0305-x","article-title":"Whole-body FDG-PET\/CT on rheumatoid arthritis of large joints","volume":"23","author":"Kubota","year":"2009","journal-title":"Ann. Nucl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.plipres.2003.12.001","article-title":"Structure and function of choline kinase isoforms in mammalian cells","volume":"43","author":"Aoyama","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00441-014-2036-0","article-title":"Expression of choline and acetylcholine transporters in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis","volume":"359","author":"Beckmann","year":"2015","journal-title":"Cell Tissue Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14397595.2017.1280118","article-title":"Functional analysis of choline transporters in rheumatoid arthritis synovial fibroblasts","volume":"27","author":"Seki","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/art.11282","article-title":"Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium","volume":"48","author":"Roivainen","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jbspin.2015.11.009","article-title":"GC\/TOF-MS-based metabolomic profiling in cultured fibroblast-like synoviocytes from rheumatoid arthritis","volume":"83","author":"Ahn","year":"2016","journal-title":"Jt. Bone Spine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/03009742.2016.1164242","article-title":"Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples","volume":"46","author":"Volchenkov","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00296-009-0865-z","article-title":"Characterization of synovial tissue from arthritis patients: A proton magnetic resonance spectroscopic investigation","volume":"29","author":"Hitchon","year":"2009","journal-title":"Rheumatol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00701-018-3563-3","article-title":"Amino acid tracers in PET imaging of diffuse low-grade gliomas: A systematic review of preoperative applications","volume":"160","author":"Naslund","year":"2018","journal-title":"Acta Neurochir."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fchem.2017.00124","article-title":"Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors","volume":"5","author":"Sun","year":"2017","journal-title":"Front. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2967\/jnumed.110.081349","article-title":"S-11C-methyl-L-cysteine: A new amino acid PET tracer for cancer imaging","volume":"52","author":"Deng","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","article-title":"Amino acid transporters revisited: New views in health and disease","volume":"43","author":"Kandasamy","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"274ra217","DOI":"10.1126\/scitranslmed.aaa1009","article-title":"Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo","volume":"7","author":"Venneti","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2967\/jnumed.116.182345","article-title":"Metabolic Imaging of Glutamine in Cancer","volume":"58","author":"Zhu","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"310ra169","DOI":"10.1126\/scitranslmed.aac6117","article-title":"PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2","volume":"7","author":"Witney","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-017-1283-3","article-title":"Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"19","author":"Takahashi","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4062\/biomolther.2017.220","article-title":"Imaging Cancer Metabolism","volume":"26","author":"Momcilovic","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jagannathan, N.R., and Sharma, U. (2017). Breast Tissue Metabolism by Magnetic Resonance Spectroscopy. Metabolites, 7.","DOI":"10.3390\/metabo7020025"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrclinonc.2016.108","article-title":"Non-invasive metabolic imaging of brain tumours in the era of precision medicine","volume":"13","author":"Kim","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/ar3072","article-title":"Localized 1H-NMR spectroscopy in patients with fibromyalgia: A controlled study of changes in cerebral glutamate\/glutamine, inositol, choline, and N-acetylaspartate","volume":"12","author":"Fayed","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.27430","article-title":"Increased glutamate\/glutamine compounds in the brains of patients with fibromyalgia: A magnetic resonance spectroscopy study","volume":"62","author":"Valdes","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/art.24932","article-title":"Brain involvement in rheumatoid arthritis: A magnetic resonance spectroscopy study","volume":"60","author":"Emmer","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/annrheumdis-2013-204603","article-title":"Ultrasound-guided synovial biopsy: A safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients","volume":"74","author":"Kelly","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1730","DOI":"10.21769\/BioProtoc.1730","article-title":"Stable Isotope Resolved Metabolomics Studies in Ex Vivo TIssue Slices","volume":"6","author":"Fan","year":"2016","journal-title":"Bio-Protocol"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymben.2017.01.010","article-title":"Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics","volume":"43","author":"Lane","year":"2017","journal-title":"Metab. Eng."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd4145","article-title":"Metabolic targets for cancer therapy","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: One hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00262-018-2288-8","article-title":"The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: Results from a phase I clinical trial","volume":"68","author":"Huijts","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(18)31649-0","article-title":"Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): A multicentre, open-label, randomised non-inferiority trial","volume":"392","author":"Lansky","year":"2018","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Petrera, M., Paleari, L., Clavarezza, M., Puntoni, M., Caviglia, S., Briata, I.M., Oppezzi, M., Mislej, E.M., Stabuc, B., and Gnant, M. (2018). The ASAMET trial: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2 x 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-5126-7"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/09553002.2017.1294272","article-title":"MLN4924 and 2DG combined treatment enhances the efficiency of radiotherapy in breast cancer cells","volume":"93","author":"Oladghaffari","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.39608","article-title":"Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes","volume":"68","author":"Divakaruni","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbi.2017.04.015","article-title":"Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism","volume":"270","author":"Yadav","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","article-title":"Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect","volume":"1870","author":"Sun","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Epstein, T., Gatenby, R.A., and Brown, J.S. (2017). The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185085"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-016-0281-0","article-title":"Hypoxia and its implications in rheumatoid arthritis","volume":"23","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fphar.2016.00184","article-title":"Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis","volume":"7","author":"Hua","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1136\/annrheumdis-2015-208476","article-title":"Dysregulated bioenergetics: A key regulator of joint inflammation","volume":"75","author":"Biniecka","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41598-017-03921-4","article-title":"Hif-1alpha Knockdown Reduces Glycolytic Metabolism and Induces Cell Death of Human Synovial Fibroblasts Under Normoxic Conditions","volume":"7","author":"Valin","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1alpha is a critical transcription factor for IL-10-producing B cells in autoimmune disease","volume":"9","author":"Meng","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tvjl.2004.01.027","article-title":"Measurements of C-reactive protein in serum and lactate dehydrogenase in serum and synovial fluid of patients with osteoarthritis","volume":"169","author":"Hurter","year":"2005","journal-title":"Vet. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e3892","DOI":"10.1002\/nbm.3892","article-title":"Increased hyperpolarized [1-13C] lactate production in a model of joint inflammation is not accompanied by tissue acidosis as assessed using hyperpolarized 13C C-labelled bicarbonate","volume":"31","author":"Wright","year":"2018","journal-title":"NMR Biomed."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-013-2362-z","article-title":"Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1alpha), in patients with refractory solid tumors","volume":"73","author":"Jeong","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2018-213103","article-title":"Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis","volume":"77","author":"Bustamante","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fimmu.2018.01973","article-title":"Inhibition of Glycolysis Reduces Disease Severity in an Autoimmune Model of Rheumatoid Arthritis","volume":"9","author":"Abboud","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"42412","DOI":"10.1038\/srep42412","article-title":"3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17\/Treg cell differentiation and suppressing dendritic cell activation","volume":"7","author":"Okano","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13075-019-1865-3","article-title":"Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis","volume":"21","author":"Song","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1177271918801005","DOI":"10.1177\/1177271918801005","article-title":"Identifying Reliable Diagnostic\/Predictive Biomarkers for Rheumatoid Arthritis","volume":"13","author":"Shervington","year":"2018","journal-title":"Biomark. Insights"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fcell.2018.00079","article-title":"Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect","volume":"6","author":"Wiese","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2011.00049","article-title":"Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review","volume":"2","author":"Porporato","year":"2011","journal-title":"Front. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/art.40569","article-title":"JAK\/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis","volume":"70","author":"McGarry","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/dna.2017.4048","article-title":"Pyruvate Kinase M2 Modulates the Glycolysis of Chondrocyte and Extracellular Matrix in Osteoarthritis","volume":"37","author":"Yang","year":"2018","journal-title":"DNA Cell Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1084\/jem.20130252","article-title":"Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells","volume":"210","author":"Yang","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bph.13762","article-title":"Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis","volume":"174","author":"Zou","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1038\/srep15171","article-title":"Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway","volume":"5","author":"Veras","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Haas, R., Smith, J., Rocher-Ros, V., Nadkarni, S., Montero-Melendez, T., D\u2019Acquisto, F., Bland, E.J., Bombardieri, M., Pitzalis, C., and Perretti, M. (2015). Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions. PLoS Biol., 13.","DOI":"10.1371\/journal.pbio.1002202"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1038\/srep13092","article-title":"Stearic acid induces proinflammatory cytokine production partly through activation of lactate-HIF1alpha pathway in chondrocytes","volume":"5","author":"Miao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family--Structure and functional characterization","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1042\/BJ20050927","article-title":"Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2)","volume":"392","author":"Srinivas","year":"2005","journal-title":"Biochem. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/14728222.2018.1511706","article-title":"Lactate transporters as therapeutic targets in cancer and inflammatory diseases","volume":"22","author":"Pucino","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/0008-5472.CAN-18-0221","article-title":"Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients","volume":"78","author":"Miloushev","year":"2018","journal-title":"Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3808","article-title":"Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells","volume":"18","author":"Shen","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1021\/acs.jproteome.6b00654","article-title":"Targeted Metabolic Profiling of the Tg197 Mouse Model Reveals Itaconic Acid as a Marker of Rheumatoid Arthritis","volume":"15","author":"Michopoulos","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.20160061","article-title":"GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis","volume":"213","author":"Sarret","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1096\/fj.201800285","article-title":"Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes","volume":"32","author":"Saraiva","year":"2018","journal-title":"FASEB J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: A new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_102","first-page":"A19","article-title":"The role of glutamate signalling in rheumatoid arthritis","volume":"85","author":"Flood","year":"2008","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/jor.23482","article-title":"Global and targeted metabolomics of synovial fluid discovers special osteoarthritis metabolites","volume":"35","author":"Zheng","year":"2017","journal-title":"J. Orthop. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1148\/radiol.2017162610","article-title":"In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine","volume":"287","author":"Dunphy","year":"2018","journal-title":"Radiology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fcell.2018.00096","article-title":"The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology","volume":"6","author":"Scalise","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fmolb.2018.00049","article-title":"A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines","volume":"5","author":"Barding","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc3162","article-title":"Choline metabolism in malignant transformation","volume":"11","author":"Glunde","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/annrheumdis-2014-205696","article-title":"Choline kinase inhibition in rheumatoid arthritis","volume":"74","author":"Guma","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12933-016-0340-6","article-title":"Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: An imaging study with positron emission tomography tracer 18F-fluoromethylcholine","volume":"15","author":"Hellberg","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Sanchez-Lopez, E., Zhong, Z., Stubelius, A., Sweeney, S.R., Booshehri, L.M., Antonucci, L., Liu-Bryan, R., Lodi, A., Terkeltaub, R., and Lacal, J.C. (2019). Choline uptake and metabolism modulate macrophage IL-1b and IL-18. Cell Metab., in press.","DOI":"10.1016\/j.cmet.2019.03.011"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.1074\/jbc.RA118.003180","article-title":"Choline transport links macrophage phospholipid metabolism and inflammation","volume":"293","author":"Snider","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.joca.2014.12.016","article-title":"Inflammation and intracellular metabolism: New targets in OA","volume":"23","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1126\/science.aab4138","article-title":"Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress","volume":"351","author":"Toyama","year":"2016","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cmet.2011.01.009","article-title":"AMPK-dependent phosphorylation of ULK1 induces autophagy","volume":"13","author":"Zhao","year":"2011","journal-title":"Cell Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41590-018-0296-7","article-title":"N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation","volume":"20","author":"Wen","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Guma, M., Wang, Y., Viollet, B., and Liu-Bryan, R. (2015). AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140452"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.198.Supp.206.17","article-title":"A potential target for methotrexate in macrophages: AMP-activated protein kinase","volume":"198","author":"Cudrici","year":"2017","journal-title":"J. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"BSR20181995","DOI":"10.1042\/BSR20181995","article-title":"AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases","volume":"39","author":"Lu","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","article-title":"Metformin Suppresses Systemic Autoimmunity in Roquin(san\/san) Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK\/mTOR\/STAT3","volume":"198","author":"Lee","year":"2017","journal-title":"J. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1681\/ASN.2018010050","article-title":"Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin","volume":"29","author":"Lee","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"973986","DOI":"10.1155\/2014\/973986","article-title":"Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/Treg balance and osteoclastogenesis","volume":"2014","author":"Son","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5","DOI":"10.23937\/2469-5726\/1510005","article-title":"Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation","volume":"1","author":"Yan","year":"2015","journal-title":"J. Rheum. Dis. Treat."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","article-title":"Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis","volume":"16","author":"Kang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3389\/fimmu.2018.01236","article-title":"Metformin and Autoimmunity: A \u201cNew Deal\u201d of an Old Drug","volume":"9","author":"Ursini","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"eaam6641","DOI":"10.1126\/sciimmunol.aam6641","article-title":"The metabolic regulator mTORC1 controls terminal myeloid differentiation","volume":"2","author":"Lee","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/aps.2015.68","article-title":"Toward rapamycin analog (rapalog)-based precision cancer therapy","volume":"36","author":"Meng","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: Results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cytogfr.2017.11.001","article-title":"Nuclear sirtuins and inflammatory signaling pathways","volume":"38","author":"Mendes","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11926-016-0606-8","article-title":"Erratum to: The Role of Sirtuins in Cartilage Homeostasis and Osteoarthritis","volume":"18","author":"Mobasheri","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Correa, M.G., Pires, P.R., Ribeiro, F.V., Pimentel, S.P., Cirano, F.R., Napimoga, M.H., Casati, M.Z., and Casarin, R.C.V. (2018). Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204414"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/rheumatology\/kew255","article-title":"Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis model","volume":"55","author":"Loureiro","year":"2016","journal-title":"Rheumatology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s10067-018-4080-8","article-title":"Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: A clinical study","volume":"37","author":"Khojah","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2147\/CIA.S172758","article-title":"Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: A pilot interventional study","volume":"13","author":"Hussain","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Rodriguez, A.E., Ducker, G.S., Billingham, L.K., Martinez, C.A., Mainolfi, N., Suri, V., Friedman, A., Manfredi, M.G., Weinberg, S.E., and Rabinowitz, J.D. (2019). Serine Metabolism Supports Macrophage IL-1beta Production. Cell Metab.","DOI":"10.1016\/j.cmet.2019.01.014"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fimmu.2018.00053","article-title":"Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte\/Macrophage Immune Responses","volume":"9","author":"Yoon","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"16040","DOI":"10.1038\/ncomms16040","article-title":"BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases","volume":"8","author":"Papathanassiu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00726-017-2520-4","article-title":"Fibroblast-like synoviocyte migration is enhanced by IL-17-mediated overexpression of L-type amino acid transporter 1 (LAT1) via the mTOR\/4E-BP1 pathway","volume":"50","author":"Yu","year":"2018","journal-title":"Amino Acids"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 Macrophages: Oracles of Health and Disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12603","article-title":"Metabolic regulation of macrophage phenotype and function","volume":"280","author":"Saha","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_142","first-page":"358","article-title":"Arginase levels are increased in patients with rheumatoid arthritis","volume":"17","author":"Huang","year":"2001","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1182\/blood-2008-12-195354","article-title":"Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes","volume":"113","author":"Sharma","year":"2009","journal-title":"Blood"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1158\/1078-0432.CCR-16-2272","article-title":"First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies","volume":"23","author":"Beatty","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ygyno.2017.07.005","article-title":"A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer","volume":"146","author":"Kristeleit","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","article-title":"Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer","volume":"336","author":"Prendergast","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_148","first-page":"1935","article-title":"Increased degradation of tryptophan in blood of patients with rheumatoid arthritis","volume":"30","author":"Schroecksnadel","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/art.24446","article-title":"Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1\/Th17 cells in the joint in collagen-induced arthritis","volume":"60","author":"Criado","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2205","article-title":"Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice","volume":"9","author":"Szanto","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","article-title":"Fatty acid synthase (FASN) as a therapeutic target in breast cancer","volume":"21","author":"Menendez","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/cam4.711","article-title":"Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway","volume":"5","author":"Wang","year":"2016","journal-title":"Cancer Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bbrc.2015.05.108","article-title":"Up-regulation of fatty acid synthase induced by EGFR\/ERK activation promotes tumor growth in pancreatic cancer","volume":"463","author":"Bian","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature20117","article-title":"Fatty acid synthesis configures the plasma membrane for inflammation in diabetes","volume":"539","author":"Wei","year":"2016","journal-title":"Nature"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-15-0126","article-title":"Molecular Pathways: Fatty Acid Synthase","volume":"21","author":"Jones","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Yamashita, Y., Nishiumi, S., Kono, S., Takao, S., Azuma, T., and Yoshida, M. (2017). Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3554-4"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1158\/0008-5472.CAN-09-0775","article-title":"Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism","volume":"69","author":"Tamura","year":"2009","journal-title":"Cancer Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1038\/s41598-018-24633-3","article-title":"Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression","volume":"8","author":"Su","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/5\/753\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:55:21Z","timestamp":1760187321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/5\/753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":158,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["jcm8050753"],"URL":"https:\/\/doi.org\/10.3390\/jcm8050753","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]}}}